Dr. Fernando Camargo is a Principal Investigator at Boston Children’s Hospital and Professor in the Department of Stem Cell and Regenerative Biology at Harvard University. Dr. Camargo’s laboratory’s ultimate goal is to understand the signals that regulate adult stem cell maturation and tissue regeneration and has a strong interest in studying the cellular and molecular biology of hematopoietic stem cells.

Featured Resource: Human Hematopoietic Stem and Progenitor Cell Phenotyping Wallchart

Resources and Links

A New Blood Test to Predict Alzheimer’s Disease – Accumulations of a sticky protein called amyloid-β can appear in the brain decades before a person develops Alzheimer’s disease.

Zika Is Not Alone in Its Effects on Fetal Damage – Many viruses, including some similar to Zika, can infect the placenta and the cells of the baby.

CRISPR to Treat Muscle Disorder – Genome editing with CRISPR/Cas9 is a promising new approach for correcting or mitigating disease-causing mutations like that of Duchenne muscular dystrophy.

Development of a New Influenza Vaccine – Researchers present a systematic approach for vaccine development that eliminates interferon–modulating functions genome-wide while maintaining virus replication fitness.

Researchers Create First Primate Clones – Scientists successfully cloned cynomolgus monkeys by somatic cell nuclear transfer.

Scientists Culture Human Placenta Stem Cells– Cells need certain proteins activated and others inhibited to stay alive and maintain the same characteristics they would have in utero.

Why Nerve Cells Die in ALS –  A mutation in a gene, called C9ORF72, leads to toxicity in nerve cells, causing 10 percent of all cases of ALS and an additional 10 percent of frontotemporal dementia.

Photo Reference: Courtesy of Dr. Fernando Camargo